Overview

This symposium will comprehensively cover the latest clinical and experimental breakthroughs in the percutaneous treatment of coronary artery disease. Those attending will be exposed to the latest clinical trial data on current and second generation drug-eluting stent device-based therapies. 

Controversies, including resistance and selection, of antiplatelet therapy as adjunctive treatment with percutaneous intervention will be discussed along with the use of imaging tools and how to manage complex lesions. Utilizing both didactic and case-based presentations, attendees will be exposed to the latest clinical and evidence-based medicine options to optimize patient outcomes in the treatment of coronary artery disease.

This event is not part of the official ACC Annual Scientific Session and/or the American College of Cardiology’s Innovation in Intervention: i2 Summit in partnership with the Cardiovascular Research Foundation (CRF) as planned by their Program Committees.